Using a combination of cytochrome P450 1B1 and β-catenin for early diagnosis and prevention of colorectal cancer

This publication has 32 references indexed in Scilit:

• Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis
  Clinical Cancer Research, 2005
• Adherence with colorectal cancer screening guidelines: a review
  Preventive Medicine, 2004
• Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients
  Toxicology Letters, 2004
• Expression of genes in the TGF-β signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice
  Toxicology and Applied Pharmacology, 2004
• Differential Toxicogenomic Responses to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Malignant and Nonmalignant Human Airway Epithelial Cells
  Toxicological Sciences, 2002
• The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1
  British Journal of Cancer, 2002
• Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells
  Carcinogenesis, 1997
• Colorectal cancer screening: Recommendations of the U.S. Preventive Services Task Force
  Gastroenterology, 1996
• A genetic model for colorectal tumorigenesis
  Cell, 1990
• Genetic Alterations during Colorectal-Tumor Development
  New England Journal of Medicine, 1988